cancer

The microdevice can be used to observe how cancer cells interact with vascular and blood cells and test novel ways to treat the disease.

A new multi-institutional program aims to develop scientists who can turn discoveries in the lab into therapies for cancer patients.

To improve the efficacy of immunotherapies, a Texas A&M team uses nanoparticles to change the environment inside a tumor, giving immune cells the upper hand.

A cost-effective model for predicting a genetic risk for melanoma is receiving international endorsements.

A portion of the bills were covered by the Gary Sinise Foundation, which helps military veterans and their families.

Astatine-211, a candidate for targeted alpha-particle therapy, decays in hours. Researchers have delineated a purification process that can extract it in minutes, increasing the amount of the element available for use.

Treatments targeting the motility system of the bacteria could eliminate the risk of antibiotic resistance.

A study found that disrupting the metabolic pathway in the initiation, growth and progression of melanoma could lead to development of new treatments.

A Texas A&M team will research noninvasive infrared light to treat glioblastomas.

The easy-to-use, cost-effective tool, which will be offered through the Texas A&M Gastrointestinal Lab, represents a significant development in veterinary medicine.